Canopy Growth's average Accounts Receivable for the
three
months ended in Mar. 2025 was $32.1 Mil. Canopy Growth's Revenue for the
three
months ended in Mar. 2025 was $45.3 Mil.
Hence, Canopy Growth's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 64.72.
The historical rank and industry rank for Canopy Growth's Days Sales Outstanding or its related term are showing as below:
CGC'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.86 Med: 51.81 Max: 62.73
Current: 58.86
During the past 13 years, Canopy Growth's highest Days Sales Outstanding was 62.73. The lowest was 17.86. And the median was 51.81.
CGC's Days Sales Outstanding is ranked better than 65.02% of 949
companies
in the Drug Manufacturers industry
Industry Median: 72.61
vs CGC: 58.86
Canopy Growth's Days Sales Outstanding
increased
from Mar. 2024 (60.40) to Mar. 2025 (64.72).
Canopy Growth Days Sales Outstanding Historical Data
The historical data trend for Canopy Growth's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Canopy Growth's Days Sales Outstanding
For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Canopy Growth's Days Sales Outstanding Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Canopy Growth's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Canopy Growth (NAS:CGC) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Canopy Growth Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Canopy Growth's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CGC has been successfully added to your 